News
10-03-2018, 02:00 AM
Scientists at the University of Toronto's Leslie Dan Faculty of Pharmacy have seen remarkable success combining tumor modulating nanoparticles with doxorubicin to enhance chemotherapy response in pre-clinical model breast cancer.
More... (https://www.news-medical.net/news/20181003/Combination-approach-appears-to-improve-chemotherapy-response-boost-anti-tumor-immunity.aspx)
More... (https://www.news-medical.net/news/20181003/Combination-approach-appears-to-improve-chemotherapy-response-boost-anti-tumor-immunity.aspx)